Research in the Sander group is focused on understanding the molecular mechanisms that underlie the formation and function of insulin-producing beta cells in the pancreas, which are affected in diabetes. Our laboratory aims to identify strategies for beta cell regeneration and replacement in order to develop novel treatments for diabetes.

To understand cellular processes leading to diabetes, we employ genetic human pluripotent stem cell (hPSC)-based and mouse models. We interrogate these models with massively parallel sequencing and bioinformatic approaches and use functional assays to link molecular phenotypes to cell function and whole body physiology.

Our research is multi-disciplinary and highly collaborative. As part of the NIH-funded Human Islet Research Network (HIRN) we are generating a 3D islet organoid on a Chip and as part of the NIH-funded T2D-GENES Consortium we are using hPSC models to establish how genetic risk for diabetes causes cellular phenotypes.

We are looking for a postdoctoral researcher/senior scientist for integrative analysis of single cell data.

Dr. Maike Sander receives the Humboldt Research Award

@msanderlab

- May 12, 2021

@AttieLab: My department has an open tenure track-track faculty position. Please spread the word. https://t.co/uYGzQ4yJ3l
h J R
@msanderlab

- May 12, 2021

@JeffreyRMillman @WUSTLmed Congratulations! So well-deserved.
h J R
@msanderlab

- May 10, 2021

I very much look forward to meeting the next generation of physician scientists. #mdphd https://t.co/tW2CFLIyVd
h J R
@msanderlab

- May 5, 2021

@INBiosciences: SAVE THE DATE: Summer is just around the corner. We're pleased to announce the line up for our Summer of Science seminar series starting July 7 with Maike Sander from the @msanderlab at @UCSanDiego. To learn more, register for these free seminars visit: https://t.co/EU0pdFWnTs https://t.co/GKjcqDcVpu
h J R